Search Results - "Frieri, G"

Is mesalazine treatment effective in the prevention of diverticulitis? A review by Stefanelli, G, Viscido, A, Valvano, M, Vernia, F, Frieri, G, Ashktorab, H, Latella, G

“…Diverticulitis is the most severe form of Diverticular disease (DD). An effective treatment strategy for its prevention has not yet been defined. This review…”
Get more information

Infliximab in spondyloarthropathy associated with Crohn’s disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations by Generini, S, Giacomelli, R, Fedi, R, Fulminis, A, Pignone, A, Frieri, G, Del Rosso, A, Viscido, A, Galletti, B, Fazzi, M, Tonelli, F, Matucci-Cerinic, M

“…Objective: To evaluate the efficacy and tolerability of anti-tumour necrosis factor α (TNFα) monoclonal antibody (infliximab) in the treatment of…”
Get full text

The dyspeptic macrophage 30 years later: An update in the pathogenesis of Crohn's disease by Caprilli, R, Frieri, G

“…Abstract Alterations in autophagy leading to a defective intracellular response to low-level invasive bacteria are considered a major recent advance in the…”
Get full text

P.09.11 ASSOCIATION BETWEEN COLORECTAL POLYPS AND COLONIC DIVERTICULOSIS by Ciccone, F, Valerii, G, Gabrieli, D, Calcina, S, Capannolo, A, Viscido, A, Melideo, D, Frieri, G, Necozione, S, Latella, G

Get full text

Boswellia serrata and Salvia miltiorrhiza extracts reduce DMN-induced hepatic fibrosis in mice by TGF-beta1 downregulation by Sferra, R, Vetuschi, A, Catitti, V, Ammanniti, S, Pompili, S, Melideo, D, Frieri, G, Gaudio, E, Latella, G

“…Hepatic fibrosis is characterised by a progressive accumulation of fibrillar extracellular matrix (ECM) proteins, including collagen that occurs in chronic…”
Get more information

P.03.10 FUNCTIONAL DYSPEPSIA: IS DUODENAL BIOPSY WORTHWHILE? by Capannolo, A, Gabrieli, D, Ciccone, F, Viscido, A, Necozione, S, Serva, D, Frieri, G

Get full text

Mucosal 5-aminosalicylic acid concentration inversely correlates with severity of colonic inflammation in patients with ulcerative colitis by Frieri, G, Giacomelli, R, Pimpo, M, Palumbo, G, Passacantando, A, Pantaleoni, G, Caprilli, R

“…BACKGROUND AND AIM The treatment of ulcerative colitis (UC) with 5-aminosalicylic acid (5-ASA) does not have the same therapeutic effect in all patients. We…”
Get full text

P.06.6 SUBTYPES OF CHRONIC GASTRITIS IN PATIENTS WITH COELIAC DISEASE BEFORE AND AFTER GLUTEN-FREE DIET by Gabrieli, D, Valerii, G, Ciccone, F, Di Ruscio, M, Serva, D, Capannolo, A, Viscido, A, Melideo, D, Frieri, G, Necozione, S, Latella, G

Get full text

Long-term oral plus topical mesalazine in frequently relapsing ulcerative colitis by Frieri, G., Pimpo, M., Galletti, B., Palumbo, G., Corrao, G., Latella, G., Chiaramonte, M., Caprilli, R.

“…In cross-sectional studies, it was demonstrated that the therapeutic effect of mesalazine is closely related to its mucosal concentration. This study was…”
Get full text

P.05.12 COLONIC MUCOSAL ORGAN CULTURE: ITS OPPORTUNISTIC USE TO DETECT CELIAC DISEASE by Picarelli, A, Borghini, R, Isonne, C, Di Tola, M, Marino, M.C, Casale, R, Puzzono, M, Ventura, F, Urciuoli, C, Tiberti, A, Pica, R, Frieri, G

Get full text

Mesalazine vanishing time from rectal mucosa following its topical administration by Pimpo, M.T., Galletti, B., Palumbo, G., Viscido, A., Gentile, P., Caprilli, R., Frieri, G.

“…To investigate how long and how much Mesalazine (M) is available inside the rectal mucosa following its topical instillation, in patients (pts) with Ulcerative…”
Get full text

Assessment of inflammatory activity in Crohn's disease by means of dynamic contrast-enhanced MRI by Pupillo, V A, Di Cesare, E, Frieri, G, Limbucci, N, Tanga, M, Masciocchi, C

“…Our aim was to perform a dynamic study of contrast enhancement of the intestinal wall in patients with Crohn's disease to quantitatively assess local…”
Get full text

Short-chain fatty acid topical treatment in distal ulcerative colitis by Vernia, P, Marcheggiano, A, Caprilli, R, Frieri, G, Corrao, G, Valpiani, D, Di Paolo, M C, Paoluzi, P, Torsoli, A

“…Some evidence indicates that short-chain fatty acid (SCFA) enemas are effective in the treatment of distal ulcerative colitis. In a randomized, double-blind,…”
Get more information

Early acid perception in NERD by Frieri, G., Antonini, F., Tanga, M., Saltarelli, P., Melideo, D., Chiaramonte, M.

“…SUMMARY Heartburn is the hallmark of gastroesophageal reflux disease. The hypothesis tested in this study is that the time of onset of this symptom may play a…”
Get full text

P.06.15 SAFETY OF ANTI-TNFA THERAPY IN IBD: AN ITALIAN EXPERIENCE by Angelucci, E, Cesarini, M, Cocco, A, Galletti, B, Foglietta, T, De Nitto, D, Alvino, M, Latella, G, Pica, R, Vernia, P, Frieri, G

Get full text

P.06.14 ADHERENCE TO ANTI-TUMOR NECROSIS FACTOR ALPHA THERAPIES IN INFLAMMATORY BOWEL DISEASES: EXPERIENCE FROM FOUR REFERRAL ITALIAN CENTERS by Angelucci, E, Cesarini, M, Cocco, A, Di Paolo, M.C, Galletti, B, De Nitto, D, Latella, G, Tammaro, L, Pica, R, Vernia, P, Frieri, G

Get full text

P.75 AZATHIOPRINE WITHDRAWAL IN CROHN'S DISEASE: NEVER-ENDING STORY? by Angelucci, E, Cesarini, M, Gentile, P, Frieri, G, Caprilli, R, Latella, G

Get full text

P.74 AVAILABLE MEDICAL THERAPIES DO NOT AFFECT DEVELOPMENT OF MAJOR COMPLICATIONS AND NEED FOR SURGERY IN CROHN'S DISEASE: LONG-TERM PROSPECTIVE STUDY ON A POPULATION OF 193 CONSECUTIVE PATIENTS by Angelucci, E, Cesarini, M, Gentile, P, Necozione, S, Frieri, G, Caprilli, R, Latella, G

Get full text

OC.07.2 BECLOMETASONE DIPROPIONATE AND MESALAZINE ARE EQUALLY EFFECTIVE IN THE TREATMENT OF LYMPHOCYTIC COLITIS by Latella, G, Angelucci, E, Tsolaki, A, Saltarelli, P, Necozione, S, Frieri, G

Get full text

Combined oral sodium butyrate and mesalazine treatment compared to oral mesalazine alone in ulcerative colitis randomized, double-blind, placebo-controlled pilot study by VERNIA, P, MONTELEONE, G, GRANDINETTI, G, VILLOTTI, G, DI GIULIO, E, FRIERI, G, MARCHEGGIANO, A, PALLONE, F, CAPRILLI, R, TORSOLI, A

“…Butyrate represents the main source of energy for colonic epithelial cells; however, its availability/utilization is impaired in ulcerative colitis (UC). In…”
Get full text